Progesterone (P4) exerts its effects by binding to specific genomic (nPR-A/B) and non-genomic (mPRalpha/beta, PGRMC1/2) receptors. P4 has a role in the regulation of the ovulatory cycle, but its participation in oocyte maturation in mammals has not yet been clarified. Therefore, the aim of the present study was to characterize the protein expression of P4 receptors (PRs) in bovine oocytes and cumulus cells during in vitro maturation (IVM) and to study the effect of P4 and its receptors on oocyte developmental competence. Cumulusoocyte complexes (COCs) were subjected to IVM, in vitro fertilization, and in vitro culture. IVM was performed for 24 h in the presence or absence of P4, luteinizing hormone (LH), follicle-stimulating hormone (FSH), trilostane, promegestone (R5020), mifepristone (RU 486), or antibodies against mPRalpha or mPRbeta. Protein expression of PRs was studied by Western blotting and immunofluorescence. The results demonstrate the presence of both genomic and nongenomic PRs in bovine COCs. The dynamic changes observed in the protein expression of PRs following IVM or in response to supplementation with LH, FSH, or P4 suggest an important role during bovine oocyte maturation. Inhibition of P4 synthesis by cumulus cells or blocking of nPR and mPR alpha activity produced a decrease in bovine embryo development, indicating that P4 intracellular signaling is mediated by its interaction with nuclear and membrane PRs and is important for oocyte developmental competence.
INTRODUCTION
Many studies investigating the molecular mechanisms controlling follicular development and ovulation in mammals have demonstrated the importance of progesterone (P4) in the regulation of the ovulatory cycle [1] and in the establishment of pregnancy at a number of levels [2] . The effects of P4 are mediated by its interaction with specific P4 receptors (PR) in the female reproductive organs. These include the genomic P4 receptor (nPR), which is a member of the ligand-inducible DNA-binding superfamily of nuclear transcription factors and which consists mainly of two different isoforms, A (nPR-A) and B (nPR-B) [3] , both encoded from a single gene by transcription from alternative promoters. However, classical activation of genomic receptors is a slow and complex process, which fails to explain the rapid responses in cells to treatment with steroid hormones [4] [5] [6] [7] . In recent years, an alternative mechanism whereby P4 binds with nongenomic receptors, activating rapid signaling events independent of transcriptional or genomic regulation, has been demonstrated in mammals [8] . Nongenomic receptors include three novel putative nongenomic membrane progestin receptors (mPRa, mPRb, and mPRc). Based on amino acid sequence homology, the mPRs belong to a larger family of 11 highly conserved mammalian paralogs termed the PAQR (progestin and adipoQ receptors). Within this nomenclature, mPRa, mPRb, and mPRc are designated PAQR7, PAQR8, and PAQR5, respectively [9, 10] . Finally, P4 mediates its nongenomic effects through the nongenomic P4 receptor membrane components 1 and 2 (PGRMC1 and PGRMC2), which belong to the membraneassociated P4 receptor (MAPR) protein family [11] .
It has been shown that luteinizing hormone (LH) and follicle-stimulating hormone (FSH), two hormones responsible for follicular growth and ovulation, stimulate cumulus cell expansion [12] [13] [14] , up-regulate granulosa cell and cumulus cell nPR expression [13] [14] [15] [16] [17] and increase P4 secretion by bovine granulosa cells [18] and pig cumulus cells [15] . In addition, functional investigations involving the inhibition of nPR-A and nPR-B using the PR antagonist mifepristone (RU 486) demonstrated a reduction in the rate of ovulation in mouse and an inhibition of meiotic resumption and cumulus cell expansion in porcine oocytes [14, 19] , demonstrating the importance of the interaction of P4 with its specific receptors in the regulation of oocyte maturation and the ovulation process. Membrane progestin receptors have also been shown to participate in the resumption of meiosis in Xenopus laevis and teleost oocytes [20] [21] [22] and in porcine cumulus cell expansion [23, 24] . Finally, the primary role of PGRMC1 appears to be the mediation of the anti-apoptotic effects of P4 and sterol metabolism [11, 25] .
Despite the functional studies of PR outlined earlier, the role of P4 in meiotic maturation of mammalian oocytes requires clarification, as findings are conflicting and possibly species specific. For example, addition of P4 during bovine oocyte maturation has been reported to reduce the proportion of oocytes forming blastocysts, an effect which was partially reversed by addition of RU 486 [26] . In contrast, the addition of the P4 inhibitor aminoglutethimide (AGT) to in vitro maturation (IVM) media decreased germinal vesicle (GV) breakdown in porcine cumulus-oocyte complexes (COCs) in a reversible manner [15] . However, P4 supplementation did not reverse similar affects observed in AGT-inhibited bovine COCs [27] . Therefore, the current study was designed to test the hypothesis that P4, acting through its receptors, plays a role in oocyte maturation in cattle. The specific objectives were (i) to characterize the protein expression profile of nPR-A, nPR-B, mPRa, mPRb, PGRMC1, and PGRMC2 in immature and mature bovine COCs; (ii) to examine the affects of exogenous LH, FSH, and P4 during IVM on PR expression; (iii) to determine a functional role for cumulus cell P4 synthesis during bovine oocyte maturation; and (iv) to identify the functional relevance of COC PR expression during oocyte maturation.
MATERIALS AND METHODS

Reagents
Unless stated otherwise all reagents were purchased from Sigma-Aldrich (Poole, Dorset, U.K.).
Bovine COC Collection and IVM
Immature COCs were obtained by aspirating follicles from the ovaries of cattle slaughtered at a local abattoir. Good quality COCs were selected and washed, and groups of up to 50 COCs were placed in 500 ll maturation medium (TCM-199 supplemented with 10% [v/v] fetal calf serum [FCS] and 10 ng/ml epidermal growth factor) in a four-well dish and cultured at 398C for 24 h in a humidified atmosphere containing 5% CO 2 .
Depending on the experiment, IVM took place in the absence or presence of P4 (10, 100, or 500 ng/ml), LH (100 ng/ml; NIDDK; Harbor-UCLA Medical Center, Torrance, CA), or FSH (Folltropin; 100 ng/ml; Vetrepharm, London, ON) (n ¼ 4 replicates). To study the effect of P4 and nPR inhibition on oocyte meiotic resumption and developmental competence, IVM was performed in the presence or absence of trilostane (inhibitor of 3 b-hydroxysteroid dehydrogenase; 10 lg/ml; Stegram Pharmaceuticals Ltd., Surrey, U.K.), P4 (50 or 100 ng/ ml), promegestone (R5020; 50 or 100 ng/ml; nonmetabolizable P4 agonist), or mifepristone (RU 486; 0.1, 1, or 10 lg/ml; PR antagonist) for 24 h (n ¼ 4 replicates). Finally, inhibition of mPRa/b was performed by incubating COCs for 3 h in maturation media in the presence of specific antibodies against each isoform (1 lg/ml; n ¼ 4 replicates), followed by two washes with maturation media and incubation in maturation media for a further 21 h.
In Vitro Fertilization and In Vitro Culture
Matured COCs were washed four times in PBS and then placed in wells containing 250 ll of fertilization medium. The fertilization medium consisted of Tyrode medium with 25 mM bicarbonate, 22 mM Na-lactate, 1 mM Napyruvate, 6 mg/ml fatty acid-free bovine serum albumin (BSA), and 10 lg/ml heparin-sodium salt (184 U/mg heparin; Calbiochem, San Diego, CA) per well. Each well was inseminated with frozen-thawed Percoll-separated bull sperm (GE Healthcare Bio-sciences, Uppsala, Sweden) at a concentration of 1 3 10 6 spermatozoa per milliliter. Plates were incubated for 24 h at 398C under an atmosphere of 5% CO 2 in air with maximum humidity.
At approximately 20 h after insemination, presumptive zygotes were denuded by gentle vortexing and washed three times in PBS and twice in culture medium before being transferred to 500 ll of synthetic oviduct fluid þ 5% FCS. Dishes were incubated at 398C under an atmosphere of 5% CO 2 , 5% O 2 , and 90% N 2 with maximum humidity. Cleavage rate was recorded on Day 2 (48 h after insemination), the proportion of 8-cell embryos was recorded on Day 3, and the proportion of embryos reaching the blastocyst stage was recorded from Days 6 to 8 (Day 0 ¼ day of in vitro fertilization).
Xenopus laevis Oocyte Collection
Xenopus were primed with 50 units of equine chorionic gonadotropin 7 days in advance of injection, with 700 U human chorionic gonadotropin to induce laying. Eggs were collected in 13 MMR (2 mM CaCl 2 , 50 mM HEPES, 20 mM KCl, 10 mM MgCl2, 100 mM NaCl, and NaOH; pH 7.8), dejellied in 2% Cysteine-KOH (pH 7.8), and thoroughly washed in 13 MMR. Eggs were snap frozen in liquid N 2 , thawed, manually crushed, and centrifuged at 16 000 3 g for 10 min (48C) in order to separate the cytoplasmic extract. Phosphatase and protease inhibitors were added to the extract, and 1 mg of protein was used for Western blot analysis. The X. laevis colony was maintained according to international best practice. Experiments were licensed by the Department of Health and Children in Ireland and approved by the University's Animal Research Ethics Committee.
Protein Analysis
Western blotting. To separate the proteins according to their apparent molecular mass, SDS-PAGE was performed according to Laemmli [28] . Immature (n ¼ 100 per lane on gel) and mature oocytes (n ¼ 100 per lane on gel) were denuded of their cumulus investments by gentle pipetting and repeated washing in PBS; cumulus cells were recovered for analysis by centrifugation. Oocyte samples were resuspended in lysis buffer (M-PER Mammalian Protein Extraction Reagent, Pierce #78503; Thermo Scientific, Rockford, IL) supplemented with protease and phosphase inhibitors (Halt Protease Inhibitor Cocktail EDTA free and Halt Phosphatase Inhibitor Cocktail, Pierce #78415, #78420, respectively; Thermo Scientific) frozen and thawed three times and centrifuged for 15 min at 10 000 3 g at 48C. Proteins were extracted from bovine endometrium and corpus luteum, human breast cancer cells, and Xenopus oocytes as described above for use as positive control samples. Human breast cancer cells used in this study were MCF-7 cells (ATCC HTB-22; ATCC, Manassas, VA), which are an epithelial-like breast adenocarcinoma cell line. Proteins were denatured by boiling for 5 min at 958C in loading buffer (Laemmli Sample Buffer; #161-0737; Bio-Rad Laboratories, Inc., Hercules, CA) supplemented with 5% mercaptoethanol. The protein content of the cumulus cells and the positive control tissue samples was calculated using the Bradford Assay [29] and that of the oocyte samples by extrapolating from previously published data [30] . Ten micrograms of protein extract of cumulus cells and control samples and 100 oocytes (equivalent to approximately 12.5 lg protein [30] ) were loaded and resolved by SDS-PAGE on a 9% polyacrylamide gel. Proteins were transferred to a nitrocellulose membrane that was blocked with blocking buffer (5% nonfat dry milk in Trisbuffered saline þ Tween-20 [TBST] containing 10 mM Trizma base, 100 mM NaCl, and 0.5% Tween 20) for 1 h at room temperature. Immunoblotting was performed by incubating the membranes in blocking buffer overnight at 48C with the above-listed primary antibodies (Table 1) . Anti-GAPDH antibody was used as a loading control due to being a constitutively expressed housekeeping protein [31, 32] . Membranes were subsequently washed in TBST and incubated with the appropriate species-specific horseradish peroxidase-conjugated secondary antibodies. Following three washes for 10 min each with TBST, the signal was visualized using SuperSignal West Pico Chemiluminescent Substrate Kit (Pierce #34077; Thermo Scientific) according to the manufacturer's instructions. Band intensity was quantified using the software Scion Image for Windows, version 4.02 (Scion Corp., Frederick, MD). A minimum of four replicates were carried out for each study.
Immunoprecipitation. In order to study the specificity of the antibody against the nPR, human breast cancer cells were used as a positive control [33] . For this approach, 750 lg of protein from human breast cancer cell whole 
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lysates was incubated with 2 lg/ml of mouse monoclonal antibody Ab-8 overnight at 48C, following which 30 ll of protein G agarose beads were added and continuously agitated for 2 h at room temperature and subsequently washed repeatedly in PBS. Finally, the supernatant was removed and 13 loading buffer was added to the samples and boiled for 5 min at 958C.
Immunofluorescence. Immature (GV) and in vitro matured (metaphase II [MII]) COCs were collected as described above and washed twice in PBS. To increase the permeabilization of the antibodies, the oocytes were denuded of cumulus cells, and the zona pellucida was removed using a prewarmed (378C) pronase solution (0.5% Protease) prior to fixation in 4% formaldehyde for 15 min, followed by incubation in PBS containing 2% Triton X100 for 30 min. To avoid nonspecific binding of the antibodies, samples were blocked overnight in PBS containing 10% rabbit serum plus 0.5% BSA at 48C. To study the localization of PRs in oocytes and cumulus cells, the same antibodies described above were used at a 1:50 dilution for 3 h at room temperature. After incubation, samples were washed three times for 10 min each in PBS plus BSA. Alexa fluor 488 rabbit anti-mouse (1:500) and Alexa fluor 568 rabbit anti-goat (1:1000) were used as secondary antibodies. Cellular DNA was stained with 4 0 ,6 0 -diamidino-2-phenylindole (DAPI; 1:1000 dilution) for 10 min. After several washes with PBS plus 0.2% Triton X100 for 30 min, cells were placed on a glass slide with mounting medium and covered with a glass cover slip. Immunolabeled oocytes were analyzed using the Carl Zeiss LSM 510 UVMETA Axiovert 200M confocal system (Carl Zeiss, Jena, Germany). Images were obtained using a Plan-Neofluar 40X/1.3 oil DIC (Carl Zeiss, Jena, Germany).
P4 Production During IVM
In order to measure P4 production during IVM, media samples were collected following 24 h culture in maturation medium in the absence or presence of trilostane and/or P4 or R5020. P4 concentrations were determined using the solid phase RIA Coat-A-Count progesterone kit (Siemens Medical Solutions Diagnostics, Los Angeles, CA). One hundred microliters of medium was placed in antibody-coated tubes in duplicate. A further 750 ll of iodinated P4 tracer was added to each tube. The tubes were then incubated at room temperature for 3 h. Tubes were decanted and counted for 90 sec using a Wallac 1470 gamma counter (Wallac/Perkin Elmer, Waltham, MA). Recovery of added mass of 40 ng P4 was 99.8%. Cross-reactivity with 17-a-hydroxy P4, 5-a-dihydroxy P4, corticosterone, cortisone, and hydrocortisone was 19.5%, 13.4%, 0.57%, 0.04%, and 0.03%, respectively. Parallelism studies between the standard curve and diluted serum indicated no interference with serum. The intra-assay CVs were 16.3%, 9.9%, and 8.3%, and inter-assay CVs were 16.5%, 10.1%, and 8.3% for low, medium, and high-quality control serum pools, respectively. The assay sensitivity was 0.03 ng P4/ml of serum.
Statistical Analysis
The densitometry data from the Western blots were analyzed using ANOVA followed by Scheffe's t-test. All statistical analyses were carried out using the SPSS version 15.0 software package for Windows (SPSS, Inc., FIG. 1. Identification and localization of nPR in bovine COCs. Proteins were resolved by SDS-PAGE, and immunoblotting was performed by using a specific antibody against nPR-A (80 kDa) and nPR-B (120 kB).
A) The specificity of the antibody against nPR was tested by immunoprecipitation of human breast cancer cell proteins (750 lg). 
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Chicago, IL). Differences between groups were considered significant when Pvalues were less than 0.05.
RESULTS
Identification and Localization of PRs in Bovine COCs
nPR-A and nPR-B. The specificity of the antibody used to study the expression of nPR-A and nPR-B was confirmed by immunoprecipitation of human breast cancer cell protein, resulting in two protein bands corresponding to nPR-A (80 kDa) and nPR-B (120 kDa; Fig. 1A ). Genomic PR-B was only detected in bovine endometrium (positive control) and in cumulus cells after 24 h of IVM. In contrast, nPR-A was detected in both control samples (endometrium and luteal cells) and in immature and mature oocytes and their associated cumulus cells (Fig. 1B) . Genomic PR-A was primarily localized in the cytoplasm of GV and MII oocytes, with some labeling foci associated with the GV and MII chromatin. The cumulus cells exhibited labeling in the cytoplasm and in the cytoplasmic projections of cumulus cells from MII oocytes; the nuclei of the cumulus cells were not labeled (Fig. 1C) . mPRa and mPRb. Western blot analysis confirmed the presence of both mPRa (48 kDa) and mPRb (48 kDa) in Xenopus oocytes and in bovine COCs before and after maturation ( Fig. 2A) . Nongenomic PRa and mPRb were localized to the plasma membrane of both GV-and MII-stage oocytes. Labeling was heterogenous in the cytoplasm of their cumulus cells; some cells showed distinct labeling of the perinuclear area. The labeling pattern did not change after IVM (Fig. 2B) .
PGRMC1 and PGRMC2. Western Blot analysis confirmed the presence of PGRMC1 (24 kDa) in bovine endometrium and luteal cells, used as control samples, and in cumulus cells from GV and MII stage oocytes. PGRMC2 (26 kDa) was detected in all samples mentioned above except in bovine endometrium. However, neither PGRMC1 nor PGRMC2 was detected in (MO) . B) Localization of mPRa and mPRb in GV and MII COCs. Control immunofluorescence was performed by omitting the primary antibodies (I, IV, VII, and X). Nongenomic PRa and mPRb were visualized in red, and DNA was visualized in blue. Nongenomic PRa and mPRb were localized to the plasma membrane in GV (II and III, respectively) and MII oocytes (V and VI, respectively). Labeling for mPRa and mPRb was localized to the cytoplasm of GV cumulus cells (framed insets; VIII and IX, respectively) and MII cumulus cells (XI and XII, respectively). Bar ¼ 50 lm.
oocytes, irrespective of maturational status (Fig. 3A) . These observations were confirmed by wholemount immunocytochemistry, where labeling was only detected in the cytoplasm of the cumulus cells. PGRMC1 was localized in the perinuclear region, whereas PGRMC2 was localized throughout the cytoplasm (Fig. 3B) .
Regulation of PRs During IVM
After meiotic maturation, the protein expression of nPR-A, nPR-B, mPRa, and mPRb increased significantly in cumulus cells; in contrast, expression was significantly down-regulated in the corresponding oocytes. Furthermore, maturation resulted in a decrease in the expression of both PGRMC1 and PGRMC2 in cumulus cells (n ¼ 4; Fig. 4 ).
Expression of PRs in Presence of LH, FSH, or P4
nPR-A and nPR-B. The expression of nPR-A and nPR-B in cumulus cells following IVM was significantly higher in the LH-and FSH-treated groups compared to the nonsupplemented IVM controls. Oocyte nPR-A expression was significantly lower (P , 0.05) in the LH-and FSH-treated groups (n ¼ 4; Fig. 5A ).
P4 supplementation during IVM did not alter nPR-A expression in cumulus cells; however, oocyte nPR-A expres- PGRMC1 was visualized in red, PGRMC2 in green, and DNA was stained in blue. Control immunofluorescence was performed by omitting the primary antibodies (images from I to VI). PGRMC1 and PGRMC2 were not detected in GV (VII and XI, respectively) and MII oocytes (VIII and XII, respectively). PGRMC1 and PGRMC2 were localized in the cytoplasm of cumulus cells (framed insets) in GV COCs (IX and XIII, respectively) and in MII COCs (X and XIV, respectively). Bar ¼ 50 lm. 
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sion was down-regulated in the presence of 100 ng/ml or 500 ng/ml P4. In contrast, cumulus cell nPR-B expression increased in a dose-dependent manner in response to P4 supplementation during IVM. However, the increase in expression was only statistically significant (P , 0.05) at a P4 concentration of 500 ng/ml (n ¼ 4; Fig. 5B ). mPRa and mPRb. Though treatment with 100 ng/ml LH or 100 ng/ml FSH during IVM did not affect mPRa expression, mPRb expression was significantly reduced in mature oocytes in the presence of LH. Neither hormone affected expression of mPRa or mPRb in the cumulus cells of mature oocytes compared to controls (n ¼ 4; Fig. 6A ). Similarly, although mPRa and mPRb expression was reduced in oocytes matured in the presence of 500 ng/ml P4, cumulus cell expression of mPRa and mPRb was not modified by exposure to P4 during IVM (n ¼ 4; Fig. 6B ).
PGRMC1 and PGRCM2. Treatment with 100 ng/ml LH or 100 ng/ml FSH during IVM did not affect cumulus cell expression of PGRMC1 or PGRMC2 (n ¼ 4; Fig. 7A ). IVM of bovine COCs in the presence of P4 resulted in an increase (P , 0.05) in the expression of PGRMC1 in cumulus cells from COCs matured in the presence of 500 ng/ml P4 and an increase (P , 0.05) in the expression of PGRMC2 in cumulus cells from COCs matured in the presence of 10 ng/ml P4 compared with control samples (n ¼ 4; Fig. 7B ).
Effect of Inhibition of P4 Production on Oocyte Developmental Competence
Treatment of COCs during IVM with 50 or 100 ng/ml of P4 had no significant effect on subsequent embryo development (cleavage rate or blastocyst formation) compared with the control. However, treatment of COCs during IVM with 10 lM trilostane impaired cumulus cell expansion (Fig. 8C) and   FIG. 4 . Regulation of PRs during bovine IVM. To study the regulation of the PRs in bovine COCs, 10 lg of proteins from cumulus cells and proteins obtained from 100 oocytes were resolved by SDS-PAGE, and immunoblotting was performed by using specific antibodies against the receptors. Anti-GAPDH was used as a loading control. The upper panel shows the regulation of the expression of nPR-A, nPR-B, mPRa, mPRb, PGRMC1, and PGRMC2 before (GV) and after 24 h of IVM (MII) in cumulus cells. The lower panel shows the regulation of the expression of nPR-A, mPRa, and mPRb before (GV) and after 24 h of IVM (MII) in oocytes. Densitometry of protein bands was measured and represented as percentage of maximum 6 SEM (n ¼ 4 replicates). Columns marked with * indicate significant differences (P , 0.05). (Fig.  8D ) and blastocyst development ( Table 2 ) was abrogated in the presence of exogenous P4.
To ensure that the effects observed above were specific to P4, the experiment was repeated, replacing P4 with a nonmetabolizable progestagen, R5020 (promegestone: 17a, 21-dimethyl-19-nor-pregna-4, 9-diene-3,20-dione). Consistent with the results observed with P4, IVM in the presence of 50 or 100 ng/ml R5020 had no effect on embryo development. However, the negative effect of P4 inhibition by trilostane was abrogated in the presence of R5020 in terms of cumulus cell expansion (Fig. 8E ) and blastocyst development (n ¼ 4; Table  3 ).
FIG. 5. Expression of nPR following IVM
in the presence of LH, FSH, or P4. IVM of COCs was performed for 24 h in the absence or presence of 100 ng/ml LH or FSH (A) or 10, 100, or 500 ng/ml of P4 (B). Proteins (10 lg) from mature cumulus cells (Cc) and 100 mature oocytes (Oo) were resolved by SDS-PAGE, and expression of nPR was studied by using a specific antibody against both isoforms. Anti-GAPDH was used as a loading control. On the right, densitometry of protein bands for nPR-A and nPR-B was measured and is represented as percentage of maximum 6 SEM (n ¼ 4 replicates). Columns with different letters indicate significant differences (P , 0.05). 
Effect of nPR-A and nPR-B Inhibition on Oocyte Developmental Competence
Maturation of COCs in the presence of 0.1, 1, or 10 lM of RU 486 did not affect the percentage of cleaved oocytes or the percentage of 5-to 8-cell-stage embryos at Day 3. However, IVM with 10 lM RU 486 impaired cumulus cell expansion (Fig. 8F ) and significantly decreased blastocyst development rate at Days 7 and 8 compared with the control (n ¼ 4; Table 4 ).
Effect of mPRa and mPRb Inhibition on Oocyte Developmental Competence
IVM performed in the presence of 1 lg/ml of a specific antibody against mPRa produced a statistically significant   FIG. 6 . COC expression of mPRa and mPRb following IVM in the presence of LH, FSH, or P4. IVM of COCs was performed for 24 h in the absence or presence of 100 ng/ ml of LH or FSH (A) or 10, 100, or 500 ng/ ml of P4 (B). Protein (10 lg) from mature cumulus cells (Cc) and 100 mature oocytes (Oo) were resolved by SDS-PAGE, and protein expression was studied by using a specific antibody against both isoforms. Anti-GAPDH was used as a loading control. On the right, densitometry of protein bands for mPRa and mPRb were measured and represented as percentage of maximum 6 SEM (n ¼ 4 replicates). Columns with different letters indicate significant differences. (Table 5) . However, no effect on cleavage rate or embryo development was observed after inhibition of mPRb during IVM with a specific antibody (Table  5 ) (n ¼ 4).
DISCUSSION
This study describes for the first time the presence of genomic and nongenomic PRs in bovine COCs both before and after IVM. Genomic PR-A, nPR-B, mPRa, mPRb, PGRMC1, and PGRMC2 were detected in bovine cumulus cells, whereas nPR-A, mPRa, and mPRb were detected in bovine oocytes. The protein expression of nPR-A, nPR-B, mPRa, and mPRb increased in cumulus cells after IVM, whereas nPR-A, mPRa, and mPRb decreased in oocytes after IVM. In contrast to the increased expression of PRs in cumulus cells following IVM, the protein expression of PGRMC1 and PGRMC2 decreased. The identification and the changes observed in the expression of PRs in bovine COCs following IVM suggest important local actions of P4 during oocyte maturation. Moreover, the results indicate that the regulation of the PRs during bovine IVM is cell dependent (oocyte vs. cumulus) and receptor specific, potentially indicating a different role for each receptor in bovine oocyte maturation.
The participation of the different PRs in meiotic resumption in nonmammalian species has been comprehensively demonstrated using microinjection of specific antibodies or antisense nucleotides [7, 20, 21, [34] [35] [36] [37] . In mammals, although it has been shown that the inhibition of nPR-A and nPR-B protein expression inhibited meiotic resumption and cumulus cell expansion in pigs [14] , the role of P4 and its receptors in oocyte maturation remains to be clarified. However, the welldescribed switch from estradiol dominance to P4 dominance in the follicular fluid of preovulatory follicles in the period between the LH surge and ovulation [38] , coincident with resumption of meiosis and maturation of the oocyte, suggests a role for P4 in this process.
During follicular growth and ovulation, the enclosed oocyte is exposed initially to FSH and later to LH and P4. Our studies, in agreement with earlier findings, indicate that these hormones regulate PR expression during IVM; FSH and LH up-regulated nPR expression in granulosa and cumulus cells [13] [14] [15] [16] [17] , but down-regulated nPR-A protein expression in oocytes, as did supplementation with P4 at physiological levels. These observations suggest that P4 produced by the cumulus cells [18, 39] , and potentially stimulated by FSH and LH [13] [14] [15] 18] , may regulate the expression of its own nuclear receptors in an isoform-and cell-specific manner [40] [41] [42] [43] . To test the functional significance of our observations, cumulus cell P4 synthesis was inhibited during IVM using trilostane, an inhibitor of 3 b-hydroxysteroid dehydrogenase, an enzyme which catalyses the synthesis of P4 from pregnenolone. Although meiotic maturation and fertilization were not affected, as assessed by cleavage rate, we noted a significant reduction in blastocyst formation rate, which was completely reversed by supplementation with exogenous P4 or a P4 agonist. Similarly, nPR inhibition by RU 486 had no effect on meiotic resumption or fertilization, as assessed by cleavage rate, but significantly impaired blastocyst development; therefore, the data from the current study and earlier findings in mouse [44] suggest that the actions of P4 are mediated by nPR-A/B during maturation. Oocyte capacitation or cytoplasmic maturation is critical to the oocyte achieving developmental potential and involves numerous morphological and biochemical processes. In terms of morphological changes, the volume of the Golgi complexes is reduced while the lipid component is increased, cortical granules align just inside the oocyte membrane, and the perivitelline space becomes enlarged [45] . Biochemical changes involve temporal regulation of maternal mRNA by polyadenylation, translation, or the degradation of obsolete or damaged transcripts (reviewed in [46] ), processes which are regulated by P4 responsive genes. It is generally accepted that the relationship between cumulus cells and oocytes is important for oocyte cytoplasmic maturation and subsequent developmental competence [47] [48] [49] [50] . Although the presence of cumulus cells is important to the acquisition of oocyte developmental competence, recent FIG. 7 . COC expression of PGRMC1 and PGRMC2 following IVM in the presence of LH, FSH, or P4. IVM of COCs was performed for 24 h in the presence of 100 ng/ml of LH or FSH (A) or 10, 100, or 500 ng/ml of P4 (B). Proteins (10 lg) from cumulus cells (Cc) and 100 oocytes (Oo) were resolved by SDS-PAGE, and protein expression was studied by using a specific antibody against both isoforms. Anti-GAPDH was used as a loading control. On the right, densitometry of protein bands for PGRMC1 and PGRMC2 were measured and represented as percentage of maximum 6 SEM (n ¼ 4 replicates). Columns with different letters indicate significant differences (P , 0.05).
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APARICIO ET AL. studies suggest that the act of expansion itself or the number of cumulus cells left attached to the oocyte at the end of the maturation period is not [51] [52] [53] [54] . This would imply that the reduced cumulus cell expansion observed in the current study following the addition of chemical inhibitors of PRs or P4 synthesis reflects disrupted cumulus oocyte signaling required for cytoplasmic maturation and developmental competence as a result of P4 inhibition.
Nongenomic PR regulation during maturation appears to be more ambiguous; our findings indicate a cell-specific and isoform-specific regulation of expression by gonadotropins, LH, and FSH. Qui et al. [23] reported that LH and FSH did not affect mPRb expression during IVM in porcine oocytes; however, cumulus expansion was impaired significantly when COCs were incubated in maturation medium containing 10% (v/v) anti-mPRb serum during IVM. In contrast to Qui et al. [23] , in the current study, the expression of mPRb in oocytes was down-regulated by LH, but its inhibition did not produce changes in either cumulus cell expansion or oocyte developmental competence. However, though protein expression of mPRa was not regulated by LH, FSH, or physiological concentrations of P4, the inhibition with a specific antibody against this isoform had a negative effect on embryo development, associated with a decrease in the percentage of oocytes progressing through the early cleavage stages. Although both membrane receptors belong to the progestin and AdipoQ-receptor family and function as G-protein-coupled receptors [9, 10] , our results suggest that only mPRa plays a functional role during bovine oocyte maturation.
Previous studies have described a role for PGRMC1 in the mediation of the anti-apoptotic effects of P4 and sterol metabolism [11, 25] . Therefore, the decrease in PGRMC1 protein expression observed in cumulus cells after IVM might be characteristic of increased apoptosis in bovine cumulus cells after IVM [55] . We did not detect PGRMC1 protein expression in oocytes in the current study. This is in contrast to a recent publication that describes PGRMC1 protein expression in bovine oocytes by Western blotting and immunolocalization of the nucleus of immature oocytes and the centromeres at metaphase I and II [56] . The authors suggest a role for PGRMC1 in Aurora B activation during meiosis and mitosis, leading to homologous chromosome alignment and segregation at metaphase. In contrast to the present study, where we used 100 oocytes per lane for Western blotting, Luciano et al. [56] used 700 oocytes per lane to detect a signal. With regard to localization of the protein, we did not detect a signal in the oocyte. This may be due to the shorter incubation time employed in the current study (3 h) or the antibody used. However, the fact that we had a clear signal in the cumulus cells indicates the effectiveness of the method used.
In conclusion, the results of the present study demonstrate, for the first time, the presence of both genomic and nongenomic PRs in bovine cumulus cells and/or oocytes. The dynamic changes observed in the protein expression of PRs following IVM or in response to supplementation with LH, FSH, or P4 suggest a role for P4 during bovine oocyte maturation. Reduced embryo development following inhibition of P4 synthesis by cumulus cells or blocking of nPR or mPRa activity during IVM suggests that the intracellular signaling mediated for P4 by its interaction with nPR and or mPRa is not related to oocyte meiotic resumption, but could be associated with cytoplasmic maturation and the oocyte's subsequent potential to sustain embryo development. 
